Speaker illustration

Doctor Kristina Kopeva

Cardiology Research Institute, Tomsk NRMC, Tomsk (Russian Federation)

Member of:

European Society of Cardiology
European Heart Rythm Association

Pharmacogenetics of therapy effectiveness for anthracycline-induced cardiotoxicity

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardio-Oncology

Session: Cardiovascular Disease in Special Populations ePosters


Anthracycline-induced cardiotoxicity: the role of endothelial dysfunction

Event: Heart Failure 2021 Online Congress

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: ePoster session


Prognostic value of soluble ST2 biomarker in heart failure patients with obstructive sleep apnea syndrome

Event: EuroHeartCare - ACNAP Congress 2021

Topic: Allied Professions in Cardiovascular Care

Session: ePosters


Anthracycline-Induced Cardiotoxicity: predictors for risk assessment in women without cardiovascular diseases

Event: ESC Preventive Cardiology 2021

Topic: Biomarkers

Session: Moderated abstracts - Secondary Prevention and Rehabilitation


Prognostic role of ST2 in heart failure patients with carbohydrate metabolism disorders

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Pathophysiology

Session: Chronic Heart Failure – Pathophysiology and Mechanisms


Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction

Event: ESC Congress 2018

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic heart failure – pathophysiology and mechanisms


This platform is supported by

logo Novo Nordisk